Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014078

EVP, CFO & Treasurer sold 2,802 shares at $3.04 ($8,509)

From the SEC's structured data for this filing

Trades in this filing

Mason Michael · EVP, CFO & Treasurer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-27 Sale : show line 1 in the form −2,802 $3.04 $8,509 161,566 D
Open-market sales · 2,802 sh · avg $3.04 · $8,509
Loading xslF345X03/doc4.xml…